Better ultrasound to find serious prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial is testing if a special ultrasound with a contrast dye can better detect aggressive prostate cancer during a biopsy. It may help avoid unnecessary procedures and find cancers that need treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a prostate biopsy because of a high PSA level, a fast-rising PSA, or an abnormal digital rectal exam.
- You are a man 18 years or older.
- You have not been on an experimental drug in the last 30 days.
- You are not allergic to the contrast dye used in the ultrasound (perflutren, polyethylene glycol, or Definity).
- You have never had treatment for prostate cancer, such as hormone therapy.
- Your doctor believes you are stable enough for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new micro-ultrasound technique to standard ultrasound during prostate biopsy, using MRI results as a guide. It aims to see if the newer method finds cancer more accurately.
This trial tests whether a new imaging agent (flotufolastat F 18 PET CT) can find prostate cancer better than MRI. If you have a suspicious spot on an MRI, this study may help doctors see if the new scan is more accurate.
This trial tests a new imaging scan that combines a special PET tracer with MRI to help guide a prostate biopsy. The goal is to see if this scan can more accurately find cancer and reduce the need for extra biopsies.
This trial tests a newer way to treat certain low- to intermediate-risk prostate cancers using MRI guidance and an ultrasound probe placed through the urethra. It aims to destroy the tumor while using imaging to help target it more precisely.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.